Keli L. Hill

Array ( [id] => 7334493 [patent_doc_number] => 20040132022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods and materials relating to soluble transforming growth factor alpha-like polypeptides and polynucleotides' [patent_app_type] => new [patent_app_number] => 10/311828 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 48961 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132022.pdf [firstpage_image] =>[orig_patent_app_number] => 10311828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4441015 [patent_doc_number] => 07927786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Parkin interacting polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 10/782375 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 40 [patent_no_of_words] => 20891 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927786.pdf [firstpage_image] =>[orig_patent_app_number] => 10782375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851777 [patent_doc_number] => 20060234968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries' [patent_app_type] => utility [patent_app_number] => 10/545231 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8956 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234968.pdf [firstpage_image] =>[orig_patent_app_number] => 10545231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5914085 [patent_doc_number] => 20060128942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Method for protein isolation in anoxic conditions' [patent_app_type] => utility [patent_app_number] => 10/543524 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4008 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128942.pdf [firstpage_image] =>[orig_patent_app_number] => 10543524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840452 [patent_doc_number] => 07390781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Methods of using truncated glial cell line-derived neurotrophic factor' [patent_app_type] => utility [patent_app_number] => 10/753592 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22718 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390781.pdf [firstpage_image] =>[orig_patent_app_number] => 10753592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624846 [patent_doc_number] => 20060263351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Methods and compositions for protection against thrombolysis associated reperfusion injury' [patent_app_type] => utility [patent_app_number] => 10/540344 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15815 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263351.pdf [firstpage_image] =>[orig_patent_app_number] => 10540344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613549 [patent_doc_number] => 20060115477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Neuropilin-1 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/539402 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 24783 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115477.pdf [firstpage_image] =>[orig_patent_app_number] => 10539402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034646 [patent_doc_number] => 20070099185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein' [patent_app_type] => utility [patent_app_number] => 10/533844 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22980 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099185.pdf [firstpage_image] =>[orig_patent_app_number] => 10533844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364289 [patent_doc_number] => 20040091942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Diagnosis of tauopathies' [patent_app_type] => new [patent_app_number] => 10/682103 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11698 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091942.pdf [firstpage_image] =>[orig_patent_app_number] => 10682103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216841 [patent_doc_number] => 20050260211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells' [patent_app_type] => utility [patent_app_number] => 10/652723 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6084 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260211.pdf [firstpage_image] =>[orig_patent_app_number] => 10652723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570291 [patent_doc_number] => 07459156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Antibodies that mimic actions of neurotrophins' [patent_app_type] => utility [patent_app_number] => 10/648619 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16663 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459156.pdf [firstpage_image] =>[orig_patent_app_number] => 10648619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382227 [patent_doc_number] => 20040081984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Ocular tear growth factor-like protein' [patent_app_type] => new [patent_app_number] => 10/468372 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11780 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081984.pdf [firstpage_image] =>[orig_patent_app_number] => 10468372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7157092 [patent_doc_number] => 20050027110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Drug delivery in the nervous system' [patent_app_type] => utility [patent_app_number] => 10/626351 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5473 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20050027110.pdf [firstpage_image] =>[orig_patent_app_number] => 10626351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7352559 [patent_doc_number] => 20040048373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Method for production of neuroblasts' [patent_app_type] => new [patent_app_number] => 10/622206 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13807 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048373.pdf [firstpage_image] =>[orig_patent_app_number] => 10622206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7287149 [patent_doc_number] => 20040147019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Methods and systems for extended in vitro culture of neuronal cells' [patent_app_type] => new [patent_app_number] => 10/618076 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8846 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147019.pdf [firstpage_image] =>[orig_patent_app_number] => 10618076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069421 [patent_doc_number] => 20050244806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases' [patent_app_type] => utility [patent_app_number] => 10/520511 [patent_app_country] => US [patent_app_date] => 2003-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12562 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244806.pdf [firstpage_image] =>[orig_patent_app_number] => 10520511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263642 [patent_doc_number] => 20040241754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Modulating neuronal plasticity' [patent_app_type] => new [patent_app_number] => 10/449715 [patent_app_country] => US [patent_app_date] => 2003-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14851 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241754.pdf [firstpage_image] =>[orig_patent_app_number] => 10449715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135928 [patent_doc_number] => 20070077557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Method for identifying type-1 interferon responsive ms patients by determining trail expression' [patent_app_type] => utility [patent_app_number] => 10/513312 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7891 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077557.pdf [firstpage_image] =>[orig_patent_app_number] => 10513312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827748 [patent_doc_number] => 20060063143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Immortalized hypothalamic neuronal cell lines' [patent_app_type] => utility [patent_app_number] => 10/511591 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14840 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063143.pdf [firstpage_image] =>[orig_patent_app_number] => 10511591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005117 [patent_doc_number] => 20050170430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway' [patent_app_type] => utility [patent_app_number] => 10/512513 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8518 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170430.pdf [firstpage_image] =>[orig_patent_app_number] => 10512513 [rel_patent_id] =>[rel_patent_doc_number] =>)